Name
OÜ Nõmme Loomakliinik
Registry code
11160468
VAT number
EE101049818
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
25.08.2005 (19)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
75001 - Veterinary activities
288 250 €
61 653 €
21%
1 261 €
(estimate is approximate)
176 647 €
4
Submitted
No tax arrears
35%
31%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Ursula Mesikäpp 20.05.1978 (46) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| Elmo Teesaar 08.01.1971 (53) | - | - | - | Founder |
| 2019 30.10.2020 | 2020 30.06.2021 | 2021 01.07.2022 | 2022 04.07.2023 | 2023 28.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 255 372 € | 254 817 € | 251 452 € | 254 360 € | 288 250 € |
| Net profit (loss) for the period | 8 241 € | 8 710 € | 33 747 € | 38 105 € | 61 653 € |
| Profit Margin | 3% | 3% | 13% | 15% | 21% |
| Current Assets | 86 287 € | 62 638 € | 50 767 € | 51 812 € | 59 103 € |
| Fixed Assets | 142 455 € | 138 315 € | 138 315 € | 138 315 € | 138 315 € |
| Total Assets | 228 742 € | 200 953 € | 189 082 € | 190 127 € | 197 418 € |
| Current Liabilities | 16 724 € | 23 325 € | 21 506 € | 16 446 € | 20 771 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 212 018 € | 177 628 € | 167 576 € | 173 681 € | 176 647 € |
| Employees | 3 | 3 | 2 | 3 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 73 001.77 € | 17 210.07 € | 10 583.89 € | 4 |
| 2023 Q4 | 68 972.95 € | 14 854.72 € | 9 703.45 € | 4 |
| 2023 Q3 | 64 813.31 € | 20 662.71 € | 9 210.51 € | 5 |
| 2023 Q2 | 84 582.69 € | 14 051.94 € | 6 837.16 € | 5 |
| 2023 Q1 | 59 797.7 € | 11 954.57 € | 6 212.94 € | 3 |
| 2022 Q4 | 60 287.53 € | 13 397.63 € | 6 675.06 € | 4 |
| 2022 Q3 | 58 811.79 € | 13 310.94 € | 7 206.83 € | 4 |
| 2022 Q2 | 80 589.23 € | 11 425.92 € | 6 001.42 € | 4 |
| 2022 Q1 | 57 234.96 € | 10 357.95 € | 4 928.46 € | 4 |
| 2021 Q4 | 62 904.26 € | 12 784.68 € | 4 040.52 € | 3 |
| 2021 Q3 | 52 703.38 € | 10 717.65 € | 4 422.54 € | 4 |
| 2021 Q2 | 77 359.35 € | 10 942.48 € | 4 361.57 € | 4 |
| 2021 Q1 | 62 056.63 € | 15 868.44 € | 4 396.24 € | 3 |
| 2020 Q4 | 61 283.34 € | 10 467.95 € | 4 413.7 € | 3 |
| 2020 Q3 | 57 856.53 € | 11 773.83 € | 6 348.64 € | 4 |
| 2020 Q2 | 66 472.66 € | 10 952.85 € | 5 714.75 € | 3 |
| 2020 Q1 | 64 032.88 € | 9 694.04 € | 5 715.15 € | 3 |
